• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经药物治疗无效的溃疡性结肠炎患者接受手术时发生的门肠系膜静脉血栓形成。

Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis.

机构信息

Division of Gastroenterology, Department of Medicine.

Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

出版信息

Inflamm Bowel Dis. 2020 Jan 6;26(2):283-288. doi: 10.1093/ibd/izz169.

DOI:10.1093/ibd/izz169
PMID:31372644
Abstract

BACKGROUND

Portomesenteric venous thrombosis (PMVT) is an under-recognized complication of colorectal surgery. The aim of this study was to describe the rate and risk factors for PMVT in patients undergoing surgery for medically refractory ulcerative colitis (UC).

METHODS

A retrospective review of medically refractory UC patients who underwent surgery between January 2010 and December 2016 at a single tertiary care center was conducted. PMVT was defined as thrombus within the portal, splenic, superior, or inferior mesenteric vein on postoperative abdominal computed tomography scans. Factors associated with PMVT on univariable analysis were tested in multivariable analysis. Clinical relevance of risk factors was examined with receiver operating characteristic curves and Kaplan-Meier curves.

RESULTS

A total of 434 patients were identified. Postoperative venous thromboembolism (VTE) prophylaxis was administered to 428 (98.5%) inpatients for a mean duration of 7.7 ± 0.17 days. PMVT developed in 36 (8.3%) patients a mean interval of 55.3 ± 10.8 days after index surgery. The majority of PMVT occurred after subtotal colectomy, and the most common initial symptom was abdominal pain. Preoperative C-reactive protein (CRP) was associated with PMVT (odds ratio, 1.01; 95% confidence interval, 1.00-1.02; P = 0.01), and the optimal predictive CRP threshold was 45 mg/L. The rate of PMVT development was greater for patients with CRP >45 mg/L (P = 0.01).

CONCLUSIONS

PMVT can present as abdominal pain and occur multiple weeks after discharge. Further studies are needed to identify the appropriate postoperative outpatient thrombosis prophylaxis regimen for at-risk patients.

摘要

背景

门静脉肠系膜静脉血栓形成(PMVT)是结直肠手术后未被充分认识的并发症。本研究旨在描述接受手术治疗的医学难治性溃疡性结肠炎(UC)患者发生 PMVT 的发生率和危险因素。

方法

对 2010 年 1 月至 2016 年 12 月在一家三级医疗中心接受手术治疗的医学难治性 UC 患者进行了回顾性研究。术后腹部 CT 扫描显示门静脉、脾静脉、肠系膜上静脉或肠系膜下静脉内血栓形成定义为 PMVT。单变量分析中与 PMVT 相关的因素在多变量分析中进行了测试。通过受试者工作特征曲线和 Kaplan-Meier 曲线检查危险因素的临床相关性。

结果

共确定了 434 名患者。428 名住院患者(98.5%)接受了术后静脉血栓栓塞症(VTE)预防治疗,平均持续时间为 7.7±0.17 天。36 名患者(8.3%)在指数手术后平均 55.3±10.8 天出现 PMVT。大多数 PMVT 发生在次全结肠切除术后,最常见的初始症状是腹痛。术前 C 反应蛋白(CRP)与 PMVT 相关(比值比,1.01;95%置信区间,1.00-1.02;P=0.01),最佳预测 CRP 阈值为 45mg/L。CRP>45mg/L 的患者 PMVT 发生率更高(P=0.01)。

结论

PMVT 可表现为腹痛,发生在出院后数周。需要进一步研究以确定高危患者术后门诊血栓预防方案。

相似文献

1
Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis.经药物治疗无效的溃疡性结肠炎患者接受手术时发生的门肠系膜静脉血栓形成。
Inflamm Bowel Dis. 2020 Jan 6;26(2):283-288. doi: 10.1093/ibd/izz169.
2
Risk factors associated with portomesenteric venous thrombosis in patients undergoing restorative proctocolectomy for medically refractory ulcerative colitis.在因内科治疗无效的溃疡性结肠炎接受结直肠切除回肠贮袋肛管吻合术的患者中,与门静脉肠系膜静脉血栓形成相关的危险因素。
Colorectal Dis. 2016 Apr;18(4):393-9. doi: 10.1111/codi.13275.
3
Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study.评估袖状胃切除术后发生门腔静脉血栓形成的危险因素、表现和处理:一项多中心病例对照研究。
Surg Obes Relat Dis. 2018 Apr;14(4):478-483. doi: 10.1016/j.soard.2017.10.013. Epub 2017 Oct 26.
4
Portomesenteric venous thrombosis following major colon and rectal surgery: incidence and risk factors.结直肠癌大手术后的门静脉肠系膜静脉血栓形成:发病率及危险因素
Surg Endosc. 2015 May;29(5):1071-9. doi: 10.1007/s00464-014-3788-z. Epub 2014 Aug 27.
5
Is Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy Related to Short-Course Prophylaxis of Thromboembolism? A Monocentric Retrospective Analysis About an Infrequent but Not Rare Complication and Review of the Literature.腹腔镜袖状胃切除术后门静脉肠系膜静脉血栓形成与短期血栓栓塞预防有关吗?关于一种不常见但并非罕见并发症的单中心回顾性分析及文献综述
J Laparoendosc Adv Surg Tech A. 2017 Oct;27(10):987-996. doi: 10.1089/lap.2017.0190. Epub 2017 Jun 12.
6
Postoperative Portomesenteric Venous Thrombosis After Colorectal Cancer Surgery.结直肠癌手术后肠系膜门静脉血栓形成。
J Gastrointest Surg. 2020 Feb;24(2):396-404. doi: 10.1007/s11605-018-04085-w. Epub 2019 Jan 22.
7
Portomesenteric vein thrombosis after gastric surgery.胃手术后门静脉肠系膜静脉血栓形成
Gastric Cancer. 2016 Oct;19(4):1135-1143. doi: 10.1007/s10120-015-0562-4. Epub 2015 Nov 5.
8
Factors associated with portomesenteric venous thrombosis after total colectomy with ileorectal anastomosis or end ileostomy.全结肠切除回直肠吻合术或回肠造口术后门静脉肠系膜静脉血栓形成的相关因素。
Am J Surg. 2018 Jan;215(1):62-65. doi: 10.1016/j.amjsurg.2017.10.002. Epub 2017 Oct 6.
9
Portomesenteric vein thrombosis following sleeve gastrectomy: Case report focusing on the role of pathogenetic factors.袖状胃切除术后门静脉肠系膜静脉血栓形成:聚焦发病因素作用的病例报告
Obes Res Clin Pract. 2022 Mar-Apr;16(2):170-173. doi: 10.1016/j.orcp.2022.03.005. Epub 2022 Apr 5.
10
Single-Dose enoxaparin for portomesenteric venous thrombosis prophylaxis after sleeve gastrectomy.单剂量依诺肝素预防袖状胃切除术后门腔静脉血栓形成。
Ann Afr Med. 2024 Jan-Mar;23(1):46-52. doi: 10.4103/aam.aam_133_23.

引用本文的文献

1
Venous Thromboembolism Prophylaxis in Inflammatory Bowel Disease Inpatients: Systematic Review and Meta-Analysis.炎症性肠病住院患者的静脉血栓栓塞症预防:系统评价和荟萃分析。
Acta Haematol. 2024;147(6):702-715. doi: 10.1159/000538086. Epub 2024 Mar 1.
2
Splanchnic Vein Thrombosis in Inflammatory Bowel Disease: An Observational Study from the ENEIDA Registry and Systematic Review.炎症性肠病中的内脏静脉血栓形成:来自ENEIDA注册研究的观察性研究及系统评价
J Clin Med. 2023 Nov 28;12(23):7366. doi: 10.3390/jcm12237366.
3
Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
炎症性肠病患者门静脉系统血栓形成的流行病学及危险因素:一项系统评价和Meta分析
Front Med (Lausanne). 2022 Jan 17;8:744505. doi: 10.3389/fmed.2021.744505. eCollection 2021.
4
High incidence of postoperative silent venous thromboembolism in ulcerative colitis: a retrospective observational study.溃疡性结肠炎术后无症状静脉血栓栓塞发生率高:一项回顾性观察研究。
BMC Surg. 2021 May 19;21(1):247. doi: 10.1186/s12893-021-01250-y.
5
Incidence and risk factors for venous thrombosis among patients with inflammatory bowel disease in China: a multicenter retrospective study.中国炎症性肠病患者静脉血栓形成的发病率及危险因素:一项多中心回顾性研究
Intest Res. 2021 Jul;19(3):313-322. doi: 10.5217/ir.2020.00017. Epub 2020 Nov 25.
6
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery.炎症性肠病患者的静脉血栓栓塞:药物治疗和手术的作用
J Clin Med. 2020 Jul 4;9(7):2115. doi: 10.3390/jcm9072115.
7
The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease.炎症性肠病患者门静脉血栓形成的自然史、治疗方法和转归。
Inflamm Bowel Dis. 2021 Jan 19;27(2):215-223. doi: 10.1093/ibd/izaa053.